Albany Molecular breaks ground on new R&D center in India

By Elaine Rigoli

Tampa, Fla., May 18 - Albany Molecular Research, Inc. announced the construction of a new 50,000 square foot research and development center at the Shapoorji Pallonji Biotech Park in Hyderabad, India.

When completed in late 2007, the new center will conduct contract projects in early stage drug-discovery research, including custom chemical synthesis and medicinal chemistry, the company said in a news release.

In addition, the new facility will house a scale-up laboratory to develop efficient methods for producing larger quantities of active pharmaceutical ingredients and intermediates.

Based in Albany, N.Y., Albany Molecular provides chemistry services to pharmaceutical and biotechnology companies.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.